drugset

drugset / Trial / NCT06805565

A Study of ONO-1110 in Patients With Social Anxiety Disorder

NCT06805565 ↗

Phase 2 Completed 115 enrolled Ono Pharmaceutical Co., Ltd.

RandomizedParallel-groupDouble-blindTreatment

Summary

To Evaluate the Efficacy and Safety of ONO-1110 in Patients with Social Anxiety Disorder

Timeline

Start: 2025-01-31
Primary completion: 2026-05-25
Completion: 2026-05-25

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	ONO-1110	Unknown	—	—

Indications